Patient Outcomes Centricity
Our group is made up of representatives that have worked directly with the myriad of healthcare stakeholders: government affairs, market access, health economics, life sciences, and patient advocacy.
By bringing these generally isolated teams together with the sole focus of impacting patient outcomes the team at Aligned Therapeutics leverages three sets of tools to tailor coordinated personalized care.
01. Companion Diagnostics and Prognostics.
We repurpose available laboratory developed tests. With the specific focus predicting treatment response we leverage tumor mutational burden analysis linked to our research surfacing novel mechanisms of action.
02. Adjuvant Access and Treatments
We repurpose therapeutics, primarily small molecules. Many treatment options for patients are pre-determined by site of care and lags behind research innovation. With our knowledge of market access to personalized treatments linked to our ongoing repurposement research we can pave ways to access immunotherapies and even help patients get resensitized to treatments they have previously failed.
03. Real World Data and Partnerships.
We repurpose existing knowledge of patient outcomes. There is a wealth of data unavailable to most healthcare providers. We proactively partner with research groups, clinical networks, and foundations to produce real world evidence of comparative effectiveness research to begin the patient outcome driving efforts of repurposement research.